Evidence map›Paper›PMID 31919466›Full record

ArticleNature communications2020

Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC-MS/MS.

Yangyang Bian, Runsheng Zheng, Florian P Bayer, Cassandra Wong, Yun-Chien Chang, Chen Meng, Daniel P Zolg, Maria Reinecke, Jana Zecha, Svenja Wiechmann and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yangyang BianChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Runsheng ZhengChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Florian P BayerChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Cassandra WongLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
Yun-Chien ChangChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Chen MengBavarian Biomolecular Mass Spectrometry Center (BayBioMS), Technical University of Munich, Freising, Germany.
Daniel P ZolgChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Maria ReineckeChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Jana ZechaChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-8767-6294
Svenja WiechmannChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0003-1324-0743
Stephanie HeinzlmeirChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Johannes ScherrCentre for Preventive and Sports Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
Bernhard HemmerDepartment of Neurology, Klinikum Rechts der Isar, Medical Faculty, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-5985-6784
Mike BaynhamThermo Fisher Scientific, Runcorn, UK.
Anne-Claude GingrasLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-6090-4437
Oleksandr BoychenkoThermo Fisher Scientific, Germering, Germany.
Bernhard KusterChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany. kuster@tum.de.ORCID http://orcid.org/0000-0002-9094-1677

Funding

CIHR CIHR FDN 143301
6 · The paper itself

Abstract

Nano-flow liquid chromatography tandem mass spectrometry (nano-flow LC-MS/MS) is the mainstay in proteome research because of its excellent sensitivity but often comes at the expense of robustness. Here we show that micro-flow LC-MS/MS using a 1 × 150 mm column shows excellent reproducibility of chromatographic retention time (<0.3% coefficient of variation, CV) and protein quantification (<7.5% CV) using data from >2000 samples of human cell lines, tissues and body fluids. Deep proteome analysis identifies >9000 proteins and >120,000 peptides in 16 h and sample multiplexing using tandem mass tags increases throughput to 11 proteomes in 16 h. The system identifies >30,000 phosphopeptides in 12 h and protein-protein or protein-drug interaction experiments can be analyzed in 20 min per sample. We show that the same column can be used to analyze >7500 samples without apparent loss of performance. This study demonstrates that micro-flow LC-MS/MS is suitable for a broad range of proteomic applications.

Indexed as

Amino Acid SequenceCell Line, TumorChromatography, LiquidHeLa CellsHumansPeptidesProteomeProteomicsTandem Mass SpectrometryPeptidesProteome

Identifiers

PMID31919466
PMCPMC6952431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.